Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:27 Mar 2017 03:30:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1251.10 [ -2.77% ]TCS 2412.05 [ -0.62% ]

Sensex29233.44
-187.96 -0.64%

Nifty9045.20
-62.80 -0.69%

Midcap13812.46
-36.72 -0.27%

Smallcap14068.72
-8.89 -0.06%


Bse Corporate Announcements Back
Sun Pharma receives USFDA approval For generic Cymbalta
Sun Pharma receives USFDA approval For generic Cymbalta Sun Pharmaceutical Industries has announced that USFDA has granted its subsidiary a tentative approval for an abbreviated new drug application (ANDA) to market a generic version of Cymbalta, duloxetine hydrochloride delayed-release capsules. These generic duloxetine hydrochloride delayed-release capsules, 20 mg (base), 30 mg (base), and 60 mg (base) are indicated in the treatment of Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD) and Diabetic Peripheral Neuropathic Pain (DPNP) Cymbalta has annual sale of approximately US$ 3 billion in the US.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com